$23.89
+2.0%Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Last Annual Value
-55.76M
3-Year CAGR
49%
5-Year CAGR
-13%
10-Year CAGR
-17%
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Azenta, Inc. NASDAQ:AZTA | -55.76M | N/A | N/A | N/A | |
![]() BioLife Solutions, Inc. NASDAQ:BLFS | -12.13M | N/A | N/A | N/A | |
![]() Kestra Medical Technologies, Ltd. NASDAQ:KMTS | -113.81M | N/A | N/A | N/A | |
![]() NovoCure Limited NASDAQ:NVCR | -136.23M | N/A | N/A | N/A | |
![]() STAAR Surgical Company NASDAQ:STAA | -80.45M | N/A | N/A | N/A | |
![]() Neogen Corporation NASDAQ:NEOG | -1.09B | N/A | N/A | N/A | |
![]() Spyre Therapeutics, Inc. NASDAQ:SYRE | -155.20M | N/A | N/A | N/A | |
![]() Schrödinger, Inc. NASDAQ:SDGR | -103.27M | N/A | N/A | N/A | |
![]() Teladoc Health, Inc. NYSE:TDOC | -200.32M | N/A | N/A | N/A |
Continue your AZTA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.